Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,708 | -40,346 | -34,511 | -34,765 | -23,068 |
| Depreciation Amortization | 1,619 | 1,563 | 1,379 | -1,006 | 371 |
| Accounts receivable | 204 | 32 | 438 | -298 | 2,684 |
| Other Working Capital | 1,654 | 2,193 | 1,271 | 559 | 2,878 |
| Other Operating Activity | -621 | 3,728 | 7,113 | 8,768 | 2,325 |
| Operating Cash Flow | $-32,852 | $-32,830 | $-24,310 | $-26,742 | $-14,810 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,717 | 3,100 | 34,120 | 26,615 | -65,299 |
| PPE Investments | -1,556 | -745 | -5,568 | -1,961 | -1,406 |
| Other Investing Activity | 0 | 0 | 1,354 | -3 | -110 |
| Investing Cash Flow | $-21,273 | $2,355 | $29,906 | $24,651 | $-66,815 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 200 | N/A | N/A |
| Debt Repayment | -86 | -15,043 | -1,040 | -809 | -715 |
| Common Stock Issued | 23,515 | 57,337 | 17,832 | 89 | 57,702 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -94 |
| Financing Cash Flow | $23,429 | $42,294 | $16,992 | $-720 | $56,893 |
| Beginning Cash Position | 38,757 | 26,938 | 4,350 | 7,161 | 31,893 |
| End Cash Position | 8,061 | 38,757 | 26,938 | 4,350 | 7,161 |
| Net Cash Flow | $-30,696 | $11,819 | $22,588 | $-2,811 | $-24,732 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,852 | -32,830 | -24,310 | -26,742 | -14,810 |
| Capital Expenditure | -1,556 | -745 | -5,689 | -1,961 | -1,406 |
| Free Cash Flow | -34,408 | -33,575 | -29,999 | -28,703 | -16,216 |